Albers JJ - Search Results

1

Atherosclerosis regression, plaque disruption, and cardiovascular events: a rationale for lipid lowering in coronary artery disease.

Brown BG, Zhao XQ, Sacco DE, Albers JJ. Brown BG, et al. Among authors: albers jj. Annu Rev Med. 1993;44:365-76. doi: 10.1146/annurev.me.44.020193.002053. Annu Rev Med. 1993. PMID: 8476257 Review.

2

Lipid altering or antioxidant vitamins for patients with coronary disease and very low HDL cholesterol? The HDL-Atherosclerosis Treatment Study Design.

Brown BG, Zhao XQ, Chait A, Frohlich J, Cheung M, Heise N, Dowdy A, DeAngelis D, Fisher LD, Albers J. Brown BG, et al. Can J Cardiol. 1998 Apr;14 Suppl A:6A-13A. Can J Cardiol. 1998. PMID: 9594927 Review.

3

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.

Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, Zhao XQ, Bisson BD, Fitzpatrick VF, Dodge HT. Brown G, et al. Among authors: albers jj. N Engl J Med. 1990 Nov 8;323(19):1289-98. doi: 10.1056/NEJM199011083231901. N Engl J Med. 1990. PMID: 2215615 Free article. Clinical Trial.

4

Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a).

Maher VM, Brown BG, Marcovina SM, Hillger LA, Zhao XQ, Albers JJ. Maher VM, et al. Among authors: albers jj. JAMA. 1995 Dec 13;274(22):1771-4. JAMA. 1995. PMID: 7500507 Clinical Trial.

5

Types of change in coronary stenosis severity and their relative importance in overall progression and regression of coronary disease. Observations from the FATS Trial. Familial Atherosclerosis Treatment Study.

Brown BG, Hillger L, Zhao XQ, Poulin D, Albers JJ. Brown BG, et al. Among authors: albers jj. Ann N Y Acad Sci. 1995 Jan 17;748:407-17; discussion 417-8. doi: 10.1111/j.1749-6632.1994.tb17337.x. Ann N Y Acad Sci. 1995. PMID: 7695184 Clinical Trial. No abstract available.

6

Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol.

Stewart BF, Brown BG, Zhao XQ, Hillger LA, Sniderman AD, Dowdy A, Fisher LD, Albers JJ. Stewart BF, et al. Among authors: albers jj. J Am Coll Cardiol. 1994 Mar 15;23(4):899-906. doi: 10.1016/0735-1097(94)90635-1. J Am Coll Cardiol. 1994. PMID: 8106695 Free article. Clinical Trial.

7

Effects of intensive lipid-lowering therapy on the coronary arteries of asymptomatic subjects with elevated apolipoprotein B.

Zhao XQ, Brown BG, Hillger L, Sacco D, Bisson B, Fisher L, Albers JJ. Zhao XQ, et al. Among authors: albers jj. Circulation. 1993 Dec;88(6):2744-53. doi: 10.1161/01.cir.88.6.2744. Circulation. 1993. PMID: 8252687 Clinical Trial.

8

Arteriographic view of treatment to achieve regression of coronary atherosclerosis and to prevent plaque disruption and clinical cardiovascular events.

Brown BG, Zhao XQ, Sacco DE, Albers JJ. Brown BG, et al. Among authors: albers jj. Br Heart J. 1993 Jan;69(1 Suppl):S48-53. doi: 10.1136/hrt.69.1_suppl.s48. Br Heart J. 1993. PMID: 8427765 Free PMC article. Review.

9

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.

Brown BG, Zhao XQ, Sacco DE, Albers JJ. Brown BG, et al. Among authors: albers jj. Circulation. 1993 Jun;87(6):1781-91. doi: 10.1161/01.cir.87.6.1781. Circulation. 1993. PMID: 8504494 Review.

10

Regression of atherosclerosis. Does it occur and does it have clinical meaning?

Brown BG, Zhao XQ, Poulin D, Albers JJ. Brown BG, et al. Among authors: albers jj. Eur Heart J. 1995 Jul;16 Suppl E:2-5. doi: 10.1093/eurheartj/16.suppl_e.2. Eur Heart J. 1995. PMID: 8542874 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

360 results

Search Page

Filters